1.25
price up icon25.00%   0.25
pre-market  Pre-market:  1.24   -0.01   -0.80%
loading
Mira Pharmaceuticals Inc stock is traded at $1.25, with a volume of 2.49M. It is up +25.00% in the last 24 hours and up +5.04% over the past month. Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.00
Open:
$1
24h Volume:
2.49M
Relative Volume:
7.09
Market Cap:
$20.70M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-1.6415
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
+23.76%
1M Performance:
+5.04%
6M Performance:
-7.41%
1Y Performance:
+13.64%
1-Day Range:
Value
$0.94
$1.328
1-Week Range:
Value
$0.9039
$1.328
52-Week Range:
Value
$0.51
$5.01

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name
Name
Mira Pharmaceuticals Inc
Name
Phone
813-369-5150
Name
Address
1200 BRICKELL AVENUE, MIAMI
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MIRA's Discussions on Twitter

Compare MIRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
MIRA
Mira Pharmaceuticals Inc
1.25 20.70M 0 -11.24M -4.79M -0.7615
Drug Manufacturers - General icon
LLY
Lilly Eli Co
801.65 720.02B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
211.55 373.46B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
162.99 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
75.89 336.88B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
MRK
Merck Co Inc
94.71 251.88B 64.17B 17.12B 18.10B 6.73

Mira Pharmaceuticals Inc Stock (MIRA) Latest News

pulisher
04:14 AM

Mira Pharmaceuticals expands pain management pipeline By Investing.com - Investing.com Australia

04:14 AM
pulisher
Mar 13, 2025

Mira Pharmaceuticals Develops Topical Formulation of Ketamir-2 for Pain Relief -March 13, 2025 at 09:30 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Mira Pharmaceuticals succesfully develops topical version of its therapy for localized neuropathic and inflammatory pain - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain - Corsicana Daily Sun

Mar 13, 2025
pulisher
Mar 13, 2025

Revolutionary Topical Pain Treatment: MIRA's Ketamir-2 Targets Multiple Pain Conditions - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

EXCLUSIVE: MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition With Development Of Topical Formulation For Lead Pain Treatment Candidate - Benzinga

Mar 13, 2025
pulisher
Mar 07, 2025

What is Zacks Small Cap’s Forecast for MIRA FY2024 Earnings? - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Mira Pharmaceuticals begins phase 1 trial for pain treatment By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 04, 2025

SponsoredImpartialComprehensive - Research Tree

Mar 04, 2025
pulisher
Mar 04, 2025

Urgent Boots paracetamol recall after packets found to contain a different drug - AOL

Mar 04, 2025
pulisher
Mar 04, 2025

Mira Pharmaceuticals Announces Approval And Initiation Of Phase 1 Clinical Trial For Ketamir-2 In Neuropathic Pain - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Mira Pharmaceuticals begins phase 1 trial for pain treatment - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Mira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trial - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

MIRA Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Neuropathic Pain - accessnewswire.com

Mar 04, 2025
pulisher
Mar 04, 2025

Can This Novel Ketamine Analog Outperform Gabapentin? MIRA's Neuropathic Pain Drug Enters Clinical Trials - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain - Yahoo Finance

Mar 04, 2025
pulisher
Feb 27, 2025

Tiziana stock jumps 12% on TBI drug study publication - MSN

Feb 27, 2025
pulisher
Feb 25, 2025

A little-known Chinese company made a drug that beat the world’s biggest-selling medicine - AOL

Feb 25, 2025
pulisher
Feb 18, 2025

Mira Murati's new AI startup poaches 20 OpenAI researchers - Reuters

Feb 18, 2025
pulisher
Feb 10, 2025

MediPharm Labs terminates proposed sale of Napanee facility to Kensana Health - Seeking Alpha

Feb 10, 2025
pulisher
Feb 07, 2025

Microstrategy Inc. – 8% PRF PERPETUAL USD 100 – Ser A’s (STRK) Stock: A Week-by-Week Analysis - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Monday.Com Ltd (MNDY) Shares Down Despite Recent Market Volatility - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Mira Pharmaceuticals Inc (MIRA) Stock: Evaluating the Market Performance - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Vanda Pharmaceuticals Inc (VNDA) Shares Rise Despite Market Challenges - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Air Transport Services Group Inc (ATSG) Stock: Evaluating the Market Performance - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Report: OpenAI's ex-CTO, Mira Murati, has recruited OpenAI co-founder John Schulman - Yahoo Finance

Feb 07, 2025
pulisher
Feb 06, 2025

OpenAI cofounder John Schulman is joining Mira Murati’s startup after brief stint at Anthropic - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

Kernel and Mira Launch Industry’s First $300M Secured AI API - GlobeNewswire Inc.

Feb 06, 2025
pulisher
Feb 03, 2025

Mira Network Launches $10M Grant Program for AI Builders - EIN News

Feb 03, 2025
pulisher
Feb 02, 2025

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy? - AOL

Feb 02, 2025
pulisher
Jan 31, 2025

UCalgary researchers to validate Mira Hormone Monitor - Yahoo Finance

Jan 31, 2025
pulisher
Jan 30, 2025

TEVA Stock Drops Over 5% Amid Financial Struggles - GuruFocus.com

Jan 30, 2025
pulisher
Jan 28, 2025

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 27, 2025

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 27, 2025

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 25, 2025

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 15, 2025

Wealth Enhancement Advisory Services LLC Acquires 6,454 Shares of PPL Co. (NYSE:PPL) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World

Jan 15, 2025
pulisher
Jan 07, 2025

AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com

Jan 07, 2025
pulisher
Jan 05, 2025

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance

Jan 05, 2025
pulisher
Dec 31, 2024

Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha

Dec 31, 2024
pulisher
Dec 30, 2024

Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha

Dec 30, 2024
pulisher
Dec 23, 2024

Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World

Dec 23, 2024
pulisher
Dec 22, 2024

Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa

Dec 22, 2024
pulisher
Dec 21, 2024

Mira Pharmaceuticals appoints new accounting firm - Investing.com

Dec 21, 2024
pulisher
Dec 21, 2024

Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart

Dec 21, 2024

Mira Pharmaceuticals Inc Stock (MIRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$113.35
price down icon 0.56%
drug_manufacturers_general SNY
$57.75
price up icon 0.10%
drug_manufacturers_general PFE
$25.60
price down icon 0.43%
$312.64
price up icon 0.04%
drug_manufacturers_general NVS
$109.11
price up icon 0.43%
drug_manufacturers_general MRK
$94.71
price up icon 1.46%
Cap:     |  Volume (24h):